The effectiveness of electroacupuncture in the treatment of cancer-related fatigue: a systematic review
Supportive Care in Cancer · 2026-05 · 34 (5)
DOI: 10.1007/s00520-026-10651-9 ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift Supportive Care in Cancer, online erschienen am 15.04.2026. Verfasst von Maria Eduarda Alcântara Campos und 3 weiteren Autor:innen. Beteiligte Einrichtung: Faculty of Health Sciences and Technologies, University of Brasilia (UnB), Brasilia, Brazil. me.alcampos25@gmail.com. Hauptthemen laut MEDLINE: Electroacupuncture, Neoplasms, Fatigue. Die Arbeit nennt 24 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Fundação de Apoio à Pesquisa do Distrito Federal, Universidade De Brasília.
Abstract (Originalsprache)
Introduction
Cancer-related fatigue (CRF) is a frequent, subjective, and difficult-to-manage symptom, for which few interventions have proven effective. Recent evidence suggests that electroacupuncture (EA) can reduce fatigue, although specific studies on this technique remain scarce.
Objective
To evaluate the efficacy of EA in treating CRF in cancer patients.
Methods
A systematic review registered in PROSPERO was conducted, including clinical trials assessing the effects of EA in patients with CRF. Searches were performed in the PubMed, Embase, Virtual Health Library, Scopus, and CAPES databases, with no restrictions on date, language, sex, ethnicity, or type of cancer. We assessed the methodological quality using the PEDro scale and evaluated the risk of bias using the RoB-2 tool.
Results
A total of 2,110 studies were identified. After applying inclusion criteria, five trials were included: three randomized, one non-randomized, and one single-arm clinical trial. In total, 251 patients were analyzed, 132 of whom received EA treatment. Interventions varied from two to three weekly sessions, each lasting 20 to 30 minutes, over a period of four to eight weeks. Acupuncture points and electrical frequencies (0.2–25 Hz) differed between studies. Outcomes were measured by the Brief Fatigue Inventory, Functional Assessment of Cancer Therapy – Fatigue, and European Organization for Research and Treatment of Cancer Quality of Life Questionnaire. Despite the potential benefits observed in EA-treated groups, the findings remain inconsistent.
Conclusion
EA shows promising therapeutic potential for managing CRF. However, the small number of studies, methodological heterogeneity, and small sample sizes limit generalizability. Multicenter clinical trials with larger samples and standardized protocols are needed to confirm efficacy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Faculty of Health Sciences and Technologies, University of Brasilia (UnB), Brasilia, Brazil. me.alcampos25@gmail.com.
- Faculty of Health Sciences and Technologies, University of Brasilia (UnB), Brasilia, Brazil.
- Rehabilitation Sciences Program, Department of Physiotherapy, University of Brasilia (UnB), Brasília, Brazil.
- Department of Physiotherapy, University of Brasilia (UnB), Brasilia, Brazil.
Förderung
- Fundação de Apoio à Pesquisa do Distrito Federal
- Universidade De Brasília
Zitieren
APA
Campos, M. E. A., Minari, G. L., Alves, A. T., & Matheus, L. B. G. (2026). The effectiveness of electroacupuncture in the treatment of cancer-related fatigue: a systematic review. Supportive Care in Cancer, 34(5). https://doi.org/10.1007/s00520-026-10651-9
Vancouver
Campos MEA, Minari GL, Alves AT, Matheus LBG. The effectiveness of electroacupuncture in the treatment of cancer-related fatigue: a systematic review. Supportive Care in Cancer. 2026;34(5). doi:10.1007/s00520-026-10651-9
BibTeX
@article{Campos2026,
author = {Campos, Maria Eduarda Alcântara and Minari, Gustavo Lee and Alves, Aline Teixeira and Matheus, Liana Barbaresco Gomide},
title = {The effectiveness of electroacupuncture in the treatment of cancer-related fatigue: a systematic review},
journal = {Supportive Care in Cancer},
year = {2026},
volume = {34},
number = {5},
doi = {10.1007/s00520-026-10651-9}
}
EUVIMED